Inhibition of STAT3 by Niclosamide Synergizes with Erlotinib against Head and Neck Cancer
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference40 articles.
1. Xenograft models of head and neck cancers. Head Neck Oncol. 1: 32;D Sano,2009
2. Cancer statistics, 2013;R Siegel;CA Cancer J Clin,2013
3. Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors;RJ Leeman-Neill;Clin Cancer Res,2010
4. Head and neck cancer;A Forastiere;N Engl J Med,2001
5. Preclinical modeling of EGFR inhibitor resistance in head and neck cancer;KM Quesnelle;Cancer Biol Ther,2012
Cited by 74 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pharmacological investigation of new niclosamide-based isatin hybrids as antiproliferative, antioxidant, and apoptosis inducers;Scientific Reports;2024-08-27
2. Multifaceted role of erlotinib in various cancer: nanotechnology intervention, patent landscape, and advancements in clinical trials;Medical Oncology;2024-06-12
3. Nanomedicine-Based Drug-Targeting in Breast Cancer: Pharmacokinetics, Clinical Progress, and Challenges;ACS Omega;2023-12-13
4. Combination therapy of niclosamide with gemcitabine inhibited cell proliferation and apoptosis via Wnt/β-catenin/c-Myc signaling pathway by inducing β-catenin ubiquitination in pancreatic cancer;Cancer Biology & Therapy;2023-11-02
5. High G9a Expression in DLBCL and Its Inhibition by Niclosamide to Induce Autophagy as a Therapeutic Approach;Cancers;2023-08-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3